News / Health

Researchers Offer Promising New Treatment for MS

Jessica Berman
Researchers have developed what’s being hailed as a “breakthrough” in the treatment of multiple sclerosis, a crippling autoimmune disease that attacks the outer sheath of nerve cells, eventually disabling many of those with the neurological condition. The new treatment involves sweeping away immune system cells responsible for MS.  

In multiple sclerosis, immune system white blood cells, called T cells, become misdirected, attacking the protective myelin sheath on the outside of nerve cells. In healthy individuals, T cells or leukocytes are responsible for destroying tumor cells or those infected with a virus.  

Myelin speeds the transmission of nerve impulses from the brain and spinal cord to limbs and the optic nerves, which also are insulated with myelin.  

When the myelin is destroyed, motor neuronal impulses are blocked, resulting in severe disability and blindness in many people with multiple sclerosis.  Worldwide, an estimated 2.5 million people are affected by MS.

U.S. and German researchers have developed a therapy that stops the autoimmune attack against myelin in its tracks without impairing the normal function of the immune system, according to Stephan Miller, a microbiologist and immunologist at Northwestern University in Evanston, Illinois.

Miller says the experimental treatment targets T cells in the brain that are responsible for the disease.  The therapy, Miller says, has a different mode of action from current MS treatments, which suppress the immune system.

“They will not only try to down-regulate the autoimmune response that’s actually causing the disease, but will also make patients in the long run susceptible to everyday infections and increased rates of cancer," said Miller.

The novel MS treatment involves taking billions of T cells from a patient and engineering them to carry myelin antigens.  The approach is similar to the way a vaccine works.  

Antigens are harmless proteins from a virus or bacterium that do not cause illness but stimulate the immune system to recognize and destroy disease-causing microbes so a person exposed later to an infection doesn’t become ill.

Nine MS patients in Hamburg, Germany were treated with the myelin antigens. Miller says their immune systems considered the engineered T cells to be foreign, disabling and killing the harmful leukocytes

“The dead and dying cells to which the antigens are attached get uptaken by cells in the immune system that ends up tricking the immune system into believing that these antigens are no longer dangerous, and will actually turn off the immune response against the antigens rather than turning it on," he said.

The therapy swept away the dead T cells. The experimental treatment reset the patients’ immune systems, halting the leukocytes' attack on the nerve sheaths and reducing the assault on the myelin by 50 to 75 percent.

While not a cure for MS, Miller believes it’s a step in the right direction.  

An article on a promising, new treatment for multiple sclerosis is published in the journal Science Translational Medicine.  

You May Like

US Imposes Sanctions on Alleged Honduran Drug Gang

Treasury department alleges Los Valles group is responsible for smuggling tens of thousands of kilograms of cocaine into US each month More

At 91, Marvel Creator Stan Lee Continues to Expand his Universe

Company's chief emeritus hopes to interest new generation of children in superheroes of all shapes and sizes by publishing content across multiple media platforms More

Photogallery New Drug Protects Against Virus in Ebola Family

Study by researchers at University of Texas Medical Branch, Tekmira Pharmaceuticals is first looking at drug's effectiveness after onset of symptoms More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid